COL4A3 and uremia: There was a trend toward a slower body weight loss in Col4a3−/− mice on triple therapy, which translated into a longer lifespan of some mice, but mean survival due to uremia did not reach a statistically significant difference versus Col4a3−/− mice on dual therapy (Figure 1, F and G).